In 2023, the 3 population screening programmes for cancer revealed cancer or precancerous abnormalities in more than 27,000 people. This is evident from the monitoring reports on the population screening programmes for colorectal cancer, cervical cancer and breast cancer. Taking part in population screening programmes makes it possible to prevent cancer or detect it at an early stage. In the latter case, less intensive treatment will often be possible and the chance of survival will be higher.
In total, more than four million people received an invitation to take part in a population screening programme for cancer in 2023.
Slight increase in participation rate thanks to self-sampling test kit
In mid-2023, the cervical cancer screening programme was renewed: people who receive an invitation for the first time now receive the self-sampling test kit immediately. Others receive this kit if they do not respond to the invitation within 12 weeks. In addition, women can still opt for a smear test at their GP practice. In 2023, the participation rate in this population screening programme increased slightly (by 4%).
Decline in mortality rates
The monitoring reports also contain data about the decline in mortality rates. Since the introduction of these population screening programmes, all target groups have shown a relative decline. With regard to the population screening programmes for cervical cancer and colorectal cancer, the detection of precancerous abnormalities before they turn cancerous has been a key factor in this decline. Improved treatment possibilities also play a part. The mortality rate for breast cancer has fallen by 42% (2022 compared to 1989), for cervical cancer by 32% (2022 compared to 1995) and for colorectal cancer by 27% (2022 compared to 2013).
Objectives of the population screening programmes for cancer
The population screening programmes for cancer aim to detect cancer or precancerous abnormalities at an early stage – before patients develop symptoms. This can make less intensive treatment possible.
However, population screening programmes also have drawbacks. The National Institute for Public Health and the Environment (RIVM) strives to make it possible for everyone to make an informed choice. Taking part in these three population screening programmes is free of charge and voluntary.
RIVM is responsible for coordinating these programmes in the Netherlands on behalf of the Dutch Ministry of Health, Welfare and Sport (VWS). Dutch Foundation of Population cancer screening is the organisation which executes the programmes.